Columbia University Medical Center, Irving Center for Clinical Research

New York, New York 10032

0 studies enrolling now · 1 studies all time

What they study most

Melanoma, Metastases

Studies at this site

• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed